-
1401“…BACKGROUND: American cutaneous leishmaniasis is a dermatozoonosis of compulsory notification with relevant morbidity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1402por Mueller, Yolanda K., Kolaczinski, Jan H., Koech, Timothy, Lokwang, Peter, Riongoita, Mark, Velilla, Elena, Brooker, Simon J., Chappuis, François“…Post-kala-azar dermal leishmaniasis was rare but likely to be underdiagnosed. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1403por Pereira, Luiza de Oliveira Ramos, Maretti-Mira, Ana Cláudia, Rodrigues, Káris Maria, Lima, Rosimar Baptista, de Oliveira-Neto, Manoel Paes, Cupolillo, Elisa, Pirmez, Claude, de Oliveira, Márcia Pereira“…Nested retro-transcription polymerase chain reaction was employed to investigate LRV1 presence in leishmaniasis lesions from Brazil. In endemic areas of Rio de Janeiro (RJ), no LRV1 infection was observed even with mucosal involvement. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1404por Taheri, Ahmad Reza, Mashayekhi Goyonlo, Vahid, Nahidi, Yalda, Moheghi, Nasrin, Tavakkol Afshari, Jalil“…Objective(s): In this study, the serum level of interferon-γ (IFN- γ) and interlukin-4 (IL-4) was evaluated as a marker of Th1 and Th2 immune response that influence the clinical course of cutaneous leishmaniasis . Materials and Methods: This cross-sectional study was conducted on 44 cases of cutaneous leishmaniasis (21 cases with healed lesions and 23 cases with chronic non-healing lesions. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1405“…BACKGROUND: Several lines of evidence demonstrating that innate and adaptive immunity play important roles in the defense against visceral leishmaniasis (VL). A polymorphism within the FcγRIIIB gene can lead to the expression of three variants of NA1, NA2, and the combined one (NA1/NA2) which alters affinity of IgG to its receptor. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1406por Nicodemo, Antonio Carlos, Amato, Valdir Sabbaga, Tuon, Felipe Francisco, de Souza, Regina Maia, Okay, Thelma Suely, Braz, Lúcia Maria Almeida“…SUMMARY: It is important to develop new methods for diagnosing relapses in the co-infection of visceral leishmaniasis (VL) and HIV to enable earlier detection using less invasive methods. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1407por Belo, Vinícius Silva, Struchiner, Claudio José, Barbosa, David Soeiro, Nascimento, Bruno Warlley Leandro, Horta, Marco Aurélio Pereira, da Silva, Eduardo Sérgio, Werneck, Guilherme Loureiro“…BACKGROUND: In the current context of high fatality rates associated with American visceral leishmaniasis (VL), the appropriate use of prognostic factors to identify patients at higher risk of unfavorable outcomes represents a potential tool for clinical practice. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1408por Sarkari, Bahador, Ashrafmansouri, Marzieh, Hatam, GholamReza, Habibi, Parvaneh, Abdolahi Khabisi, Samaneh“…Serological assays have been extensively evaluated for diagnosis of visceral leishmaniasis (VL) and considered as a routine method for diagnosis of VL while these methods are not properly evaluated for diagnosis of cutaneous leishmaniasis (CL). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1409por Van den Bergh, Rafael, Van Ginderachter, Jo A., Schouppe, Elio, Desimmie, Belete A., Hailu, Asrat, De Baetselier, Patrick, van Griensven, JohanEnlace del recurso
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1410por Costa, Lourena Emanuele, Goulart, Luiz Ricardo, Pereira, Nathália Cristina de Jesus, Lima, Mayara Ingrid Sousa, Duarte, Mariana Costa, Martins, Vivian Tamietti, Lage, Paula Sousa, Menezes-Souza, Daniel, Ribeiro, Tatiana Gomes, Melo, Maria Norma, Fernandes, Ana Paula, Soto, Manuel, Tavares, Carlos Alberto Pereira, Chávez-Fumagalli, Miguel Angel, Coelho, Eduardo Antonio Ferraz“…BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has become a high-priority. The present study has used the phage display technology to identify new immunogens, which were evaluated as vaccines in the murine model of visceral leishmaniasis (VL). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1411por Yared, Solomon, Deribe, Kebede, Gebreselassie, Araya, Lemma, Wessenseged, Akililu, Essayas, Kirstein, Oscar D, Balkew, Meshesha, Warburg, Alon, Gebre-Michael, Teshome, Hailu, Asrat“…BACKGROUND: Visceral leishmaniasis (VL, also called ‘’kala-azar”), is a life threatening neglected tropical infectious disease which mainly affects the poorest of the poor. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1412por Santos, Diego M., Petersen, Antonio L. O. A., Celes, Fabiana S., Borges, Valeria M., Veras, Patricia S. T., de Oliveira, Camila I.“…BACKGROUND: Leishmaniasis remains a worldwide public health problem. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1413
-
1414por Bray, Daniel P., Yaman, Khatijah, Underhilll, Beryl A., Mitchell, Fraser, Carter, Victoria, Hamilton, James G. C.“…BACKGROUND: The sand fly Phlebotomus argentipes is arguably the most important vector of leishmaniasis worldwide. As there is no vaccine against the parasites that cause leishmaniasis, disease prevention focuses on control of the insect vector. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1415por Islamuddin, Mohammad, Chouhan, Garima, Farooque, Abdullah, Dwarakanath, Bilikere S., Sahal, Dinkar, Afrin, Farhat“…BACKGROUND: In the absence of vaccines and limitations of currently available chemotherapy, development of safe and efficacious drugs is urgently needed for visceral leishmaniasis (VL) that is fatal, if left untreated. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1416
-
1417por BAMOROVAT, Mehdi, SHARIFI, Iraj, MOHAMMADI, Mohammad Ali, FASIHI HARANDI, Majid, MOHEBALI, Mehdi, MALEKPOUR AFSHAR, Reza, BABAEI, Zahra, ZIAALI, Nasser, AFLATOONIAN, Mohammad Reza“…BACKGROUND: Canine visceral leishmaniasis (CVL) is a systemic disease with a high mortality rate, caused by a diphasic protozoan parasite, Leishmania infantum/chagasi in the world. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1418por Gardinassi, Luiz Gustavo, Dotz, Viktoria, Hipgrave Ederveen, Agnes, de Almeida, Roque Pacheco, Nery Costa, Carlos Henrique, Costa, Dorcas Lamounier, de Jesus, Amélia Ribeiro, Mayboroda, Oleg A., Garcia, Gustavo Rocha, Wuhrer, Manfred, de Miranda Santos, Isabel Kinney Ferreira“…Visceral leishmaniasis (VL) has a high fatality rate if not treated; nevertheless, the majority of human infections with the causative agent, Leishmania infantum chagasi, are asymptomatic. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1419por Boettcher, Jan P, Siwakoti, Yubaraj, Milojkovic, Ana, Siddiqui, Niyamat A, Gurung, Chitra K, Rijal, Suman, Das, Pradeep, Kroeger, Axel, Banjara, Megha R“…BACKGROUND: To eliminate visceral leishmaniasis (VL) in India and Nepal, challenges of VL diagnosis, treatment and reporting need to be identified. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1420por Jafari, Mahvash, Shirbazou, Shanaz, Sadraie, Seyed Homayoon, Kaka, Gholamreza, Norozi, Majid“…BACKGROUND: Cutaneous leishmaniasis is a common parasitic disease in Iran being mainly caused by Leishmania (L.) major. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto